Skip to main content
SpringerLink
Log in

The influence of mildronate on peripheral neuropathy and some characteristics of glucose and lipid metabolism in rats with the streptozotocin model of diabetes mellitus

  • Published:
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry Aims and scope Submit manuscript

Abstract

Rats with the streptozotocin (STZ) model of diabetes mellitus were treated with mildronate (100 mg/kg daily, per os or intraperitoneally) for 6 weeks. Body weight, blood glucose, triglycerides, ketone body concentrations, percent of glycated hemoglobin (HbA1c%), glucose tolerance, and the development of neuropathic pain were monitored throughout the whole experiment. The mildronate treatment completely prevented the development of the diabetic neuropathy from the first week up to the end of experiment. In the group of diabetic animals treated with mildronate a significant decrease of blood glucose was observed on the fourth week of the treatment, the level of triglycerides decreased from the third to sixth weeks. Mildronate also decreased accumulation of glycated hemoglobin on the sixth week and improved glucose tolerance compared with untreated animals. The data obtained confirm applicability of mildronate for therapy of diabetes mellitus and its complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tomlinson, D.R. and Gardiner, N.J., Nat. Rev. Neurosci., 2008, vol. 9, pp. 36–45.

    Article  CAS  Google Scholar 

  2. Cruccu, G., Curr. Opin. Neurol., 2007, vol. 20, pp. 531–535.

    CAS  Google Scholar 

  3. Ziegler, D., Diabetes Metab. Res. Rev., 2008, Suppl. 1, pp. S52–S57.

  4. Vitale, C. and Collin, P., Curr. Pharm. Des., 2008, vol. 14, pp. 2537–2550.

    Article  CAS  Google Scholar 

  5. Sjakste, N. and Kalvins, I., Pharmacology online, 2006, vol. 1, pp. 1–18

    Google Scholar 

  6. Botabekova, T.K., Imantaeva, M.V., Zhazini, B.S., and Dzhumataeva, Z.A., Meditsina, 2004, vol. 2, pp. 69–71.

    Google Scholar 

  7. Statsenko, M.E., Poletaeva, L.V., Turkina, S.V., Apukhtin, A.F., and Dudchenko, G.P., Ter. Arkh., 2008, vol. 80, no. 10, pp. 27–30.

    CAS  Google Scholar 

  8. Statsenko, M.E., Poletaeva, L.V., Turkina, S.V., Inozemtseva, M.A., and Apukhtin, A.F., Klin. Med., 2008, vol. 86, no. 9, pp. 67–71.

    CAS  Google Scholar 

  9. Suslina, Z.A., Maksimova, M.Ya., Kistenev, B.A., Fedorova, T.N., and Kim, E.K., Farmateka, 2005, vol. 12, pp. 68–71.

    Google Scholar 

  10. Simkhovich, B.Z., Meirena, D.B., Hagi, C.B., Shutenko, J.B., Molodchina, T.N., Kalvinsh, I.Ya., and Lukevits, E.Ya., Farmakol. Toxicol., 1991, vol. 54, pp. 41–42.

    CAS  Google Scholar 

  11. Liepins, E., Vilskerts, R., Skapare, E., Svalbe, B., Kuka, J., Cirule, H., Pugovics, O., Kalvinsh, I., and Dambrova, M., Life Sci., 2008, vol. 83, pp. 613–619.

    Article  Google Scholar 

  12. Liepinsh, E., Vilskersts, R., Zvejniece, L., Svalbe, B., Skapare, E., Kuka, J., Cirule, H., Grinberga, S., Kalvinsh, I., and Dambrova, M., Br. J. Pharmacol., 2009, vol. 157, pp. 1549–1556.

    Article  CAS  Google Scholar 

  13. Asaka, N., Muranaka, Y., Kirimoto, T., and Miyake, H., Fundam. Clin. Pharmacol., 1998, vol. 12, pp. 158–163.

    Article  CAS  Google Scholar 

  14. Pupure, J., Fernandes, M.A., Santos, M.S., Moreno, A.J., Kalvinsh, I., Klusa, V., and Oliveira, C.R., Cell Biochem. Funct., 2008, vol. 26, pp. 620–631.

    Article  CAS  Google Scholar 

  15. Klusa, V., Pupure, J., Isajevs, S., Rumaks, J., Gordjushina, V., Kratovska, A., Taivans, I., Svirskis, S., Viksna, L., and Kalvinsh, I., Basic Clin. Pharmacol. Toxicol., 2006, vol. 99, pp. 323–328.

    Article  CAS  Google Scholar 

  16. Isajevs, S., Pupure, J., Gordjushina, V., Kratovska, A., Taivans, I., Viksna, L., Kalvinsh, I., Klusa, V., Proc. Latvian Acad. Sci. Part B, 2007, vol. 6, pp. 26–32.

    Google Scholar 

  17. Runge-Morris M. and Vento, C., Drug Metabol. Dispos., 1995, vol. 23, pp. 455–459.

    CAS  Google Scholar 

  18. McNeill, J.H., Experimental Models of Diabetes, CRC Press LLC, 1999.

  19. Pari, L., and Satheesh, M.A., Life Sci., 2006, vol. 79, pp. 641–645.

    Article  CAS  Google Scholar 

  20. Chandramohan, G., Ignacimuthu, S., and Pugalendi, K.V., Eur. J. Pharmacol., 2008, vol. 590, pp. 437–443.

    Article  CAS  Google Scholar 

  21. Dambrova, M., Liepinsh, E., and Kalvinsh, I., Trends Cardiovasc. Med., 2002, vol. 12, pp. 275–279.

    Article  CAS  Google Scholar 

  22. Qaseem, A., Vijan, S., Snow, V., Cross, J.T., Weiss, K., and Owens, D., Ann. Intern. Med., 2007, vol. 147, pp. 417–422.

    Google Scholar 

  23. Schopfer, F.J., Lin, Y., Baker, P.R., Cui, T., Garcia-Barrio, M., Zhang, J., Chen, K., Chen, Y.E., and Freeman, B.A., Proc. Natl. Acad. Sci. USA, 2005, vol. 102, pp. 2340–2345.

    Article  CAS  Google Scholar 

  24. Stadler, K., Jenei, V., Somogyi, A., and Jakus, J., Diabetes Metab. Res. Rev., 2005, vol. 21, pp. 189–196.

    Article  CAS  Google Scholar 

  25. Sjakste, N., Kleschyov, A.L., Boucher, J.L., Baumane, L., Dzintare, M., Meirena, D., Sjakste, J., Sydow, K., Münzel, T., and Kalvinsh, I., Eur. J. Pharmacol., 2004, vol. 495, pp. 67–73.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Latvian Institute of Organic Synthesis, Aizkraukles Street 21, Riga, LV1006, Latvia

    J. Sokolovska, J. Sharipova, I. Kalvinsh & N. Sjakste

  2. Faculty of Medicine, University of Latvia, Sharlotes Street 1a, Riga, LV1001, Latvia

    J. Rumaks, N. Karajeva, D. Grinvalde, V. Kluša & N. Sjakste

Authors
  1. J. Sokolovska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Rumaks
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Karajeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Grinvalde
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Sharipova
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. Kluša
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. Kalvinsh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. N. Sjakste
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Sokolovska.

Additional information

Original Russian Text © J. Sokolovska, J. Rumaks, N. Karajeva, D. Grinvalde, J. Sharipova, V. Klu a, I. Kalvinsh, N. Sjakste, 2012, published in Biomeditsinskaya Khimiya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sokolovska, J., Rumaks, J., Karajeva, N. et al. The influence of mildronate on peripheral neuropathy and some characteristics of glucose and lipid metabolism in rats with the streptozotocin model of diabetes mellitus. Biochem. Moscow Suppl. Ser. B 6, 177–184 (2012). https://doi.org/10.1134/S1990750812020114

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990750812020114

Keywords

Search

Navigation